221 related articles for article (PubMed ID: 22776759)
1. Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.
Mashiach-Farkash E; Rak R; Elad-Sfadia G; Haklai R; Carmeli S; Kloog Y; Wolfson HJ
Oncotarget; 2012 Jun; 3(6):629-39. PubMed ID: 22776759
[TBL] [Abstract][Full Text] [Related]
2. The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase/cofilin pathway.
Starinsky-Elbaz S; Faigenbloom L; Friedman E; Stein R; Kloog Y
Mol Cell Neurosci; 2009 Dec; 42(4):278-87. PubMed ID: 19666124
[TBL] [Abstract][Full Text] [Related]
3. Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells.
Djamai H; Berrou J; Dupont M; Kaci A; Ehlert JE; Weber H; Baruchel A; Paublant F; Prudent R; Gardin C; Dombret H; Braun T
Leuk Res; 2021 Jan; 100():106490. PubMed ID: 33373830
[TBL] [Abstract][Full Text] [Related]
4. Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways.
Vallée B; Doudeau M; Godin F; Gombault A; Tchalikian A; de Tauzia ML; Bénédetti H
PLoS One; 2012; 7(10):e47283. PubMed ID: 23082153
[TBL] [Abstract][Full Text] [Related]
5. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
Petrilli A; Copik A; Posadas M; Chang LS; Welling DB; Giovannini M; Fernández-Valle C
Oncogene; 2014 Jul; 33(27):3571-82. PubMed ID: 23934191
[TBL] [Abstract][Full Text] [Related]
6. Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase.
Sumi T; Matsumoto K; Nakamura T
J Biol Chem; 2001 Jan; 276(1):670-6. PubMed ID: 11018042
[TBL] [Abstract][Full Text] [Related]
7. Novel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft model.
Rak R; Haklai R; Elad-Tzfadia G; Wolfson HJ; Carmeli S; Kloog Y
Oncoscience; 2014; 1(1):39-48. PubMed ID: 25593987
[TBL] [Abstract][Full Text] [Related]
8. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.
Ozawa T; Araki N; Yunoue S; Tokuo H; Feng L; Patrakitkomjorn S; Hara T; Ichikawa Y; Matsumoto K; Fujii K; Saya H
J Biol Chem; 2005 Nov; 280(47):39524-33. PubMed ID: 16169856
[TBL] [Abstract][Full Text] [Related]
9. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.
Yi F; Guo J; Dabbagh D; Spear M; He S; Kehn-Hall K; Fontenot J; Yin Y; Bibian M; Park CM; Zheng K; Park HJ; Soloveva V; Gharaibeh D; Retterer C; Zamani R; Pitt ML; Naughton J; Jiang Y; Shang H; Hakami RM; Ling B; Young JAT; Bavari S; Xu X; Feng Y; Wu Y
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381571
[TBL] [Abstract][Full Text] [Related]
11. LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features.
Villalonga E; Mosrin C; Normand T; Girardin C; Serrano A; Žunar B; Doudeau M; Godin F; Bénédetti H; Vallée B
Cells; 2023 Mar; 12(5):. PubMed ID: 36899941
[TBL] [Abstract][Full Text] [Related]
12. LIMK2-1, a new isoform of human LIMK2, regulates actin cytoskeleton remodeling via a different signaling pathway than that of its two homologs, LIMK2a and LIMK2b.
Vallée B; Cuberos H; Doudeau M; Godin F; Gosset D; Vourc'h P; Andres CR; Bénédetti H
Biochem J; 2018 Dec; 475(23):3745-3761. PubMed ID: 30373762
[TBL] [Abstract][Full Text] [Related]
13. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
Charette N; De Saeger C; Lannoy V; Horsmans Y; Leclercq I; Stärkel P
Mol Cancer; 2010 Sep; 9():256. PubMed ID: 20860815
[TBL] [Abstract][Full Text] [Related]
14. The Role of LIM Kinase in the Male Urogenital System.
Park J; Kim SW; Cho MC
Cells; 2021 Dec; 11(1):. PubMed ID: 35011645
[TBL] [Abstract][Full Text] [Related]
15. LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505.
Amano T; Tanabe K; Eto T; Narumiya S; Mizuno K
Biochem J; 2001 Feb; 354(Pt 1):149-59. PubMed ID: 11171090
[TBL] [Abstract][Full Text] [Related]
16. Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice.
Haklai R; Elad-Sfadia G; Egozi Y; Kloog Y
Cancer Chemother Pharmacol; 2008 Jan; 61(1):89-96. PubMed ID: 17909812
[TBL] [Abstract][Full Text] [Related]
17. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
18. LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-beta.
Vardouli L; Moustakas A; Stournaras C
J Biol Chem; 2005 Mar; 280(12):11448-57. PubMed ID: 15647284
[TBL] [Abstract][Full Text] [Related]
19. LIMK1/2 in the mPFC Plays a Role in Chronic Stress-Induced Depressive-Like Effects in Mice.
Gao TT; Wang Y; Liu L; Wang JL; Wang YJ; Guan W; Chen TT; Zhao J; Jiang B
Int J Neuropsychopharmacol; 2020 Dec; 23(12):821-836. PubMed ID: 32827213
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway.
Lee S; Helfman DM
J Biol Chem; 2004 Jan; 279(3):1885-91. PubMed ID: 14559914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
